Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Centre Leon Berard
Washington University School of Medicine
Memorial Sloan Kettering Cancer Center
Massachusetts General Hospital
M.D. Anderson Cancer Center
Seattle Children's Hospital
Nationwide Children's Hospital
The New York Proton Center
University of California, San Francisco
Baptist Health South Florida
OHSU Knight Cancer Institute
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Columbia University
Australian & New Zealand Children's Haematology/Oncology Group
Massachusetts General Hospital
Alliance for Clinical Trials in Oncology
Abramson Cancer Center at Penn Medicine
St. Jude Children's Research Hospital
Centre Hospitalier Universitaire de la Réunion
St. Jude Children's Research Hospital
The University of Texas Health Science Center, Houston
Seattle Children's Hospital
Seattle Children's Hospital
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University
Seattle Children's Hospital
Mayo Clinic
Institut Curie
Baylor College of Medicine
Cedars-Sinai Medical Center
M.D. Anderson Cancer Center
Barbara Ann Karmanos Cancer Institute
Children's National Research Institute
Cedars-Sinai Medical Center
Rigshospitalet, Denmark
Thomas Jefferson University
Thomas Jefferson University
Dana-Farber Cancer Institute
Medical College of Wisconsin
Institut Curie
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Universitätsmedizin Mannheim
Rigshospitalet, Denmark